Kymera Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2019 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Kymera Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q2 2024.
Kymera Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $1.9M, a 111% increase year-over-year.
Kymera Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $5.2M, a 52.9% increase year-over-year.
Kymera Therapeutics, Inc. annual Depreciation for 2023 was $3.6M, a 20% increase from 2022.
Kymera Therapeutics, Inc. annual Depreciation for 2022 was $3M, a 25% increase from 2021.
Kymera Therapeutics, Inc. annual Depreciation for 2021 was $2.4M, a 33.3% increase from 2020.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$5.2M	$1.9M	+$1M	+111%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$4.2M	$1.5M	+$600K	+66.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$3.6M	$900K	+$100K	+12.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$3.5M	$900K	+$100K	+12.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$3.4M	$900K	+$200K	+28.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$3.2M	$900K	+$200K	+28.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	$3M	$800K	+$200K	+33.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$2.8M	$800K	+$100K	+14.3%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$2.7M	$700K	+$100K	+16.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$2.6M	$700K	+$200K	+40%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$2.4M	$600K	+$100K	+20%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	$2.3M	$700K	+$200K	+40%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$2.1M	$600K	+$200K	+50%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$1.9M	$500K	+$100K	+25%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	$1.8M	$500K			Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020		$500K	+$300K	+150%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$400K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-06
Q1 2020		$400K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q3 2019		$200K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.